My responsibilities include managing research programs in developmental biology, stem cell biology and the regeneration of endocrine tissue and organs. I direct a program in islet biology that supports mechanistic studies to understand integrated islet function, beta cell renewal, and pathophysiology.
In addition, I help to coordinate research in the Human Islet Research Network (HIRN), a basic science research effort which is developing innovative strategies for the treatment, prevention and monitoring of type 1 diabetes. Within HIRN, I serve as the project scientist for the Consortium on Human Islet Biomimetics (CHIB), and am the program officer for the Consortium on Targeting and Regeneration (CTAR), and the Consortium on Beta Cell Death and Survival (CBDS). In addition, I serve as the program officer for the Integrated Islet Distribution Program.
In addition to my duties in the Division of Diabetes, Endocrinology, and Metabolic Diseases, I also participate in NIDDK working groups that focus on genetics and genomics, obesity, stem cells, and type 1 diabetes.